title: Commentary on the clinical trial reported by: Tewari KS, Sill M, Long III HJ, et al. Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: a phase III randomized trial of the Gynecologic Oncology Group. J Clin Oncol 2013;(suppl; abstr 3).
authors.affiliation: Gynaecological Cancer Centre, Royal Hospital for Women, Randwick, Sydney 2031, Australia. m.friedlander@unsw.edu.au.
authors.forename: Michael L
authors.initials: ML
authors.lastname: Friedlander